AMBIT BIOSCIENCES CORPORATION NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
Exhibit 10.8
AMBIT BIOSCIENCES CORPORATION
NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
On January 8, 2014, the Board, upon recommendation of the Committee, adopted a revised compensation program for the non-employee directors (the Non-Employee Director Compensation Policy), effective immediately. The Non-Employee Director Compensation Policy will apply to each of the Companys non-employee directors who the Committee determines is eligible to receive compensation under the Non-Employee Director Compensation Policy and may be amended by the Board at any time. Pursuant to the Non-Employee Director Compensation Policy, each eligible non-employee member of the Board will receive the following cash compensation for Board services, as applicable:
| $40,000 per year for service as a Board member; |
| an additional $30,000 per year for service as the Chairman of the Board; |
| an additional $15,000 per year for service as the Chairman of the Audit Committee, effective as of the 2014 annual meeting of the Companys stockholders ($10,000 per year for current term); |
| an additional $10,000 per year for service as the Chairman of the Compensation Committee; and |
| an additional $7,000 per year for service as the Chairman of the Nominating and Corporate Governance Committee. |
In addition, the Companys eligible non-employee directors will receive initial and annual, automatic, non-discretionary grants of nonqualified stock options under the terms and provisions of the Plan. Each eligible non-employee director, upon joining the Board will automatically be granted a non-statutory stock option to purchase 14,000 shares of the Companys Common Stock. Each of these initial grants will vest in equal annual installments over a three year period, subject to the directors continued service with the Company through such dates. On the date of each annual meeting of the Companys stockholders, each non-employee director will automatically be granted a non-statutory stock option to purchase 8,000 shares of the Companys Common Stock. The annual grants will vest in full on the one-year anniversary of the date of grant, subject to the directors continued service through such date. All stock options granted will have a maximum term of 10 years and will vest in full upon the closing of a change of control transaction.